Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
If you miss 3 or more consecutive days, do not resume at your current dose
One of our most innovative offerings is GLP-1 Therapy with Tirzepatide, a groundbreaking treatment designed to address weight management and chronic metabolic conditions
Achievable plans for lasting outcomes By design, the program encourages long-lasting changes to health behaviors Achieving program goals drives better outcomes for your population Delivered as a key preventive health offering within your benefits ecosystem, or part of your daily use, personalized health platform to maximize ongoing support Financial benefits & outcomes you can count on 3:1 VOI Embedded within your personalized, daily use health, wellbeing, and navigation solution 99% Satisfaction Among participants who also improved their weight, activity, and mental wellbeing Better outcomes Transform outperforms similar programs' weight loss avg by 49%
Employers want to offer something for their members, but when they see the cost, they cant afford it. Employers who address obesity treatment effectively can drive significant value in their costs and employee satisfaction. Elina Onitskansky, founder and CEO, Ilant Health Weighing the Long-Term Benefits While GLP-1 drugs were originally developed to treat diabetes by managing blood sugar levels, they now are commonly prescribed to also treat obesity
US$ 28.32
US$ 21.83
US$ 22.27
US$ 26.99
US$ 26.81
US$ 26.67
